Phibro Animal Health (PAHC) Operating Expenses (2012 - 2026)
Phibro Animal Health's (PAHC) quarterly Operating Expenses came in at $81.2 million in Q1 2026, up 13.2% year-on-year from $71.7 million in Q1 2025, and down 1.66% quarter-over-quarter from $82.5 million in Q4 2025.
Phibro Animal Health (PAHC) Operating Expenses (2012 - 2026) Analysis & Trends
Phibro Animal Health's Operating Expenses history runs 15 years deep, the most recent figure standing at $81.2 million for Q1 2026.
- On a quarterly basis, Operating Expenses rose 13.2% year-over-year to $81.2 million in Q1 2026; TTM through Mar 2026 was $299.7 million, a 1.65% increase from a year earlier, with the FY2025 full-year figure at $293.3 million, up 12.72% from the prior year.
- Operating Expenses fell to $81.2 million in Q1 2026 per PAHC's latest filing, from $82.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $85.2 million in Q4 2024 and bottomed at $52.4 million in Q1 2022.
- The 5-year median for Operating Expenses is $67.2 million (2025), against an average of $65.9 million.
- Across the five-year window, Operating Expenses declined 4.75% in 2023 and jumped 35.34% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $61.5 million in 2022, then climbed by 2.23% to $62.9 million in 2023, then soared by 35.34% to $85.2 million in 2024, then dropped by 3.09% to $82.5 million in 2025, then slipped by 1.66% to $81.2 million in 2026.
- Per Business Quant, the three latest PAHC Operating Expenses figures stand at $81.2 million (Q1 2026), $82.5 million (Q4 2025), and $68.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 81.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.15 Mn |
| Dec 31, 2025 | 82.52 Mn |
| Sep 30, 2025 | 68.78 Mn |
| Jun 30, 2025 | 67.21 Mn |
| Mar 31, 2025 | 71.69 Mn |
| Dec 31, 2024 | 85.15 Mn |
| Sep 30, 2024 | 69.22 Mn |
| Jun 30, 2024 | 68.73 Mn |
| Mar 31, 2024 | 59.68 Mn |
| Dec 31, 2023 | 62.92 Mn |
| Sep 30, 2023 | 68.45 Mn |
| Jun 30, 2023 | 52.90 Mn |
| Mar 31, 2023 | 56.99 Mn |
| Dec 31, 2022 | 61.54 Mn |
| Sep 30, 2022 | 54.96 Mn |
| Jun 30, 2022 | 55.54 Mn |
| Mar 31, 2022 | 52.43 Mn |
| Dec 31, 2021 | 48.38 Mn |
| Sep 30, 2021 | 50.07 Mn |
| Jun 30, 2021 | 50.67 Mn |